What Researchers Did
Researchers investigated whether culturing human fetal pancreas tissue with hyperbaric oxygen could reduce the immune system's response to it when transplanted.
What They Found
They found that by day 14, human immune cells (CD45 cells) made up less than 2% of cells in grafts treated with hyperbaric oxygen culture. In contrast, nearly 15% of cells in conventionally cultured grafts were human immune cells (P =.0018), with about 75% of these producing an inflammatory marker called IFNgamma. This suggests hyperbaric oxygen culture significantly reduced the immune response.
What This Means for Canadian Patients
For Canadian patients with type 1 diabetes, this research suggests a potential method to make transplanted pancreatic tissue less likely to be rejected by the body. If successful in humans, this could lead to better long-term outcomes for islet transplants and potentially reduce the need for strong immunosuppressive medications.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study was conducted using an animal model and human cells in a lab setting, meaning the findings may not directly translate to human patients.